Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus R Meyer

Showing results (11-20 of 261) with videos related to

Pageof 27
Sort By:
Archives of Toxicology|July 3, 2016
High-resolution mass spectrometry in toxicology: current status and future perspectivesH H Maurer, Markus R Meyer
Analytical and Bioanalytical Chemistry|August 26, 2011
Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agentsMarkus R Meyer, Hans H Maurer
Analytical and Bioanalytical Chemistry|February 22, 2012
Current applications of high-resolution mass spectrometry in drug metabolism studiesMarkus R Meyer, Hans H Maurer
Therapeutic Drug Monitoring|November 8, 2012
Analytical toxicology of emerging drugs of abuse--an updateMarkus R Meyer, Frank T Peters
Metabolomics : Official Journal of the Metabolomic Society|March 4, 2020
Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studiesSascha K Manier, Markus R Meyer
Archives of Toxicology|August 20, 2021
Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine doseSelina Hemmer, Lea Wagmann, Markus R Meyer
Drug and Alcohol Dependence|September 30, 2015
Prevalence and distribution patterns of amphetamine and methamphetamine consumption in a federal state in southwestern Germany using wastewater analysisMarkus R Meyer, Tina Vollerthun, Ralf Hasselbach
Drug Testing and Analysis|December 11, 2024
Studies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology ScreeningFabian Frankenfeld, Lea Wagmann, Markus R Meyer
Toxicology Letters|December 3, 2014
Contribution of human esterases to the metabolism of selected drugs of abuseMarkus R Meyer, Aline Schütz, Hans H Maurer
Archives of Toxicology|November 24, 2014
In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approachJulia Dinger, Markus R Meyer, Hans H Maurer
Pageof 27

Showing results (11-20 of 261) with videos related to

Sort By:
Pageof 27
Archives of Toxicology|July 3, 2016
High-resolution mass spectrometry in toxicology: current status and future perspectivesH H Maurer, Markus R Meyer
Analytical and Bioanalytical Chemistry|August 26, 2011
Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agentsMarkus R Meyer, Hans H Maurer
Analytical and Bioanalytical Chemistry|February 22, 2012
Current applications of high-resolution mass spectrometry in drug metabolism studiesMarkus R Meyer, Hans H Maurer
Therapeutic Drug Monitoring|November 8, 2012
Analytical toxicology of emerging drugs of abuse--an updateMarkus R Meyer, Frank T Peters
Metabolomics : Official Journal of the Metabolomic Society|March 4, 2020
Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studiesSascha K Manier, Markus R Meyer
Archives of Toxicology|August 20, 2021
Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine doseSelina Hemmer, Lea Wagmann, Markus R Meyer
Drug and Alcohol Dependence|September 30, 2015
Prevalence and distribution patterns of amphetamine and methamphetamine consumption in a federal state in southwestern Germany using wastewater analysisMarkus R Meyer, Tina Vollerthun, Ralf Hasselbach
Drug Testing and Analysis|December 11, 2024
Studies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology ScreeningFabian Frankenfeld, Lea Wagmann, Markus R Meyer
Toxicology Letters|December 3, 2014
Contribution of human esterases to the metabolism of selected drugs of abuseMarkus R Meyer, Aline Schütz, Hans H Maurer
Archives of Toxicology|November 24, 2014
In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approachJulia Dinger, Markus R Meyer, Hans H Maurer
Pageof 27